Ben is the Director of Strategic Development, for the National Biologics Facility within TIA (Therapeutic Innovation Australia).  Ben brings over 20 years of experience in commercialising biologics with a proven track record of developing successful teams and implementing compliant systems for cGMP manufacturing in both Australia and the US.  Ben has extensive experience in facility design and start-up, as well as delivering a broad range of vaccines and biologics products through process development and tech transfer to cGMP and commercial manufacture. 

Ben previously worked at Patheon by Thermo Fisher, The University of Queensland, Merck and Co, Inc., and CSL, and is a graduate of the University of New South Wales Bioprocess (Chemical) Engineering.